|
|
Volumn 66, Issue 11, 2006, Pages 1786-
|
|
Pentoxifylline in ALS: A double-blind, randomized, multicenter, placebo-controlled trial [5]
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
PENTOXIFYLLINE;
AMYOTROPHIC LATERAL SCLEROSIS;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DISEASE ASSOCIATION;
DOUBLE BLIND PROCEDURE;
DRUG EFFICACY;
HUMAN;
LETTER;
MORTALITY;
MULTICENTER STUDY;
OUTCOMES RESEARCH;
PRIORITY JOURNAL;
QUALITATIVE ANALYSIS;
RANDOMIZED CONTROLLED TRIAL;
STATISTICAL SIGNIFICANCE;
SURVIVAL;
TREATMENT OUTCOME;
AMYOTROPHIC LATERAL SCLEROSIS;
DATA INTERPRETATION, STATISTICAL;
DOUBLE-BLIND METHOD;
HUMANS;
MULTICENTER STUDIES;
NEUROPROTECTIVE AGENTS;
OUTCOME ASSESSMENT (HEALTH CARE);
PENTOXIFYLLINE;
PLACEBO EFFECT;
PLACEBOS;
PROGNOSIS;
RANDOMIZED CONTROLLED TRIALS;
RISK ASSESSMENT;
RISK FACTORS;
SURVIVAL ANALYSIS;
SURVIVAL RATE;
TREATMENT FAILURE;
|
|
EID: 33745657876
PISSN: 00283878
EISSN: None
Source Type: Journal
DOI: 10.1212/01.wnl.0000230561.21579.ad Document Type: Letter |
|
Times cited : (3)
|
|
References (0)
|
